Heartseed, Inc. (219A) Press Release
Notice on Resignation of Independent Board Director
Earlier from Heartseed
- Non-consolidated Financial Results for the Six Months Ended June 30, 2026 (Under Japanese GAAP)
- Notice Regarding the First Patient Dosed in the Phase I/II company-sponsored Clinical Trial of HS-005 (Catheter Administration) for Cardiac Remuscular